Monday, September 28, 2020
wellness India Expo
Home Tags Dr Krishna Ella

Tag: Dr Krishna Ella

#BioAsia2020: India’s Pharma & Biotech Industry aims $100 billion through innovations

Speaking on the 2nd day of BioAsia 2020, Union Minister Mr Piyush Goyal said that the patent applications will be approved in record time to enable the industry to discover innovative drugs..................

Chiron Behring re-launches its rabies vaccine as Chirorab

Earlier marketed under the trade name Rabipur®, this vaccine is presently manufactured using the same technology at the same site..................

Bharat Biotech set to acquire Chiron Behring Vaccines from GSK

The Ankleshwar, Gujarat based Chiron Behring Vaccines which is a part of GlaxoSmithKline Asia will be acquired by Bharat Biotech in an all cash transaction, subject to a number of closing conditions which both the parties intend to complete in the coming weeks................

Bharat Biotech receives National Technology Award for ROTAVAC from the President

Launched in 2015 by the Prime Minister of India, Narendra Modi ROTAVAC vaccine was introduced into the Universal Immunization Program in India during 2016, with initial implementation in 9 states with more States in the pipeline.............

India needs to follow its own model of innovation: Dr Krishna...

The Chairman of Bharat Biotech, Dr Krishna Ella in his remarks at the 6th Foundation Day event of the BIRAC at New Delhi, mentioned that the Indian biotech sector must create its own indigenous model for innovation that would cater to its needs and that of the world............